Assistant Professor, Human Oncology, University of Wisconsin Medical School
Radiation Oncology
Dr. Kevin R. Kozak, MD
|
|
Give Review
Kevin R. Kozak practices Radiation Oncology. He went to Vanderbilt University School of Medicine. Doctor Kevin R. Kozak, MD is a published physician. He has 55 papers published. The most current publication "Examination of Gossypol-Pluronic Micelles as Potential Radiosensitizers." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Examination of Gossypol-Pluronic Micelles as Potential Radiosensitizers.
- Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life.
- Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management.
- Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells.
- Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society f...
- The Role of Radiation in Retroperitoneal Sarcomas.
- Expression of angiopoietin-TIE system components in angiosarcoma.
- Dosimetric comparison of photon and proton treatment techniques for chondrosarcoma of thoracic spine.
- Acute Hematologic and Mucosal Toxicities in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: A Comparison of 3D-CRT, IMRT, and Helical Tomotherapy.
- Agreement Among RTOG Sarcoma Radiation Oncologists in Contouring Suspicious Peritumoral Edema for Preoperative Radiation Therapy of Soft Tissue Sarcoma of the Extremity.
- Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience.
- Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
- Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data.
- ANTI-TUMOR ACTIVITY OF TRIOLIMUS: A NOVEL MULTI-DRUG LOADED MICELLE CONTAINING PACLITAXEL, RAPAMYCIN AND 17-AAG.
- Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.
- Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.
- Differential Expression of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survi...
- Low Rates of Heterotopic Ossification After Resurfacing Hip Arthroplasty With Use of Prophylactic Radiotherapy in Select Patients.
- Elevation of Prostaglandin E2 in Lung Cancer Patients with Digital Clubbing.
- Proton Radiotherapy for Parameningeal Rhabdomyosarcoma: Clinical Outcomes and Late Effects.
- Refusal of radiation therapy and its associated impact on survival.
- Stewart-Treves syndrome of the lower extremity.
- Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.
- AIDS-related Kaposi's sarcoma of the gastrointestinal tract.
- Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal.
- External beam radiotherapy for colon cancer: patterns of care.
- Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
- A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
- Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
- A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonist.
- The survival impact of the intergroup 0116 trial on patients with gastric cancer.
- The impact of T and N stage on long-term survival of rectal cancer patients in the community.
- Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib.
- Stage-specific survival differences associated with postoperative radiotherapy for gastrointestinal cancers.
- Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides.
- Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment.
- AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
- Accelerated partial-breast irradiation using proton beams: initial clinical experience.
- Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice.
- Accelerated partial breast irradiation using proton beams: Initial dosimetric experience.
- Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques.
- Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2.
- Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques.
- Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation.
- The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells.
- Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of a...
- A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385.
- Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
- Hand-assisted laparoscopic radical nephrectomy-associated rhabdomyolysis with ARF.
- Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides.
- Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.
- 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist.
- A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety.
- Delivery of definitive dose external beam radiation in close proximity to an implanted deep brain stimulator.
Schools
Vanderbilt University School Of Medicine
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Boston University Medical Center -
Vanderbilt University School of Medicine
Hospital
-
University of Wisconsin Hospital and Clinics
Drug Facts
| NPI NUMBER | 1124219241 | |
| NPPES Provider LastName | KOZAK | |
| NPPES Provider FirstName | KEVIN | |
| NPPES Provider ZIPCode | 535482940 | |
| NPPES Provider State | WI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 143.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 23.08 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124219241 |
| Last Name Of The Provider | KOZAK |
| First Name Of The Provider | KEVIN |
| View All |
Similar Doctors
|
|
Donald M. Cannon |
|
|
Dr. Steven P. Howard, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Zinda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Ritter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael F. Bassetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily F. Dunn, MD |
|
|
Dr. Craig R. Hullett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Patrick S. Fernandes, MB
This Doctor is OpenDoctor Recommended.
|